REFERENCES
- Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–1140.
- Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: A review. Retina. 2014;34:827–845.
- Ferreyra HA. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127:390.
- Voltz R. Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J Neurol. 2006;253:33–38.
- Subhadra C, Dudek AZ, Rath PP, Lee MS. Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin. J Neuro-Ophthalmol. 2008;28:23–26.
- Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol. 1999;117:471–477.
- Dot C, Guigay J, Adamus G. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol. 2005;139:746–747.
- Mahdi N, Faia LJ, Goodwin J, Nussenblatt RB, Sen HN. A case of autoimmune retinopathy associated with thyroid carcinoma. Ocul Immunol Inflamm. 2010;18:322–323.
- Imai H, Ohta K, Kikuchi T, Komurasaki Y, Miyazaki D, Ikeda S-I. Cancer-associated retinopathy in a patient with seminoma. Retin Cases Brief Rep. 2012;6:159–162.
- Huynh N, Shildkrot Y, Lobo AM, Sobrin L. Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. J Ophthalmic Inflamm Infect. 2012;2:169–171.
- Dy I, Chintapatla R, Preeshagul I, Becker D. Treatment of cancer-associated retinopathy with rituximab. JNCCN J Natl Compr Cancer Netw. 2013;11:1320–1324.
- Makiyama Y, Kikuchi T, Otani A, et al. Clinical and immunological characterization of paraneoplastic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:5424–5431.
- Turaka K, Kietz D, Krishnamurti L, et al. Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary. J Aapos. 2014;18:396–398.
- Mesiwala NK, Shemonski N, Sandrian MG, et al. Retinal imaging with en face and cross-sectional optical coherence tomography delineates outer retinal changes in cancer-associated retinopathy secondary to Merkel cell carcinoma. J Ophthalmic Inflamm Infect. 2015;5:0–6.